Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Glahn

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Emerging Drugs|April 12, 2024
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorderSophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Der Nervenarzt|January 11, 2020
[Addictive disorders in physicians]Ahmad Bransi, Lotta Winter, Alexander Glahn, et al.
Clinical Epigenetics|January 22, 2022
Leptin promoter methylation in female patients with painful multisomatoform disorder and chronic widespread painJohannes Achenbach, Mathias Rhein, Alexander Glahn, et al.
Deutsches Arzteblatt International|May 30, 2018
Alcohol Biomarkers in Clinical and Forensic ContextsHilke Andresen-Streichert, Alexander Müller, Alexander Glahn, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|November 24, 2020
[Central pontine myelinolysis during qualified alcohol withdrawal therapy. A case report]Phileas J Proskynitopoulos, Gregor Szycik, Stefan Bleich, et al.
BMC Psychiatry|June 26, 2015
Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imagingAlexander Glahn, Tino Prell, Julian Grosskreutz, et al.
European Addiction Research|March 22, 2019
Thiamine Substitution in Alcohol Use Disorder: A Narrative Review of Medical GuidelinesNathalie Pruckner, Josef Baumgartner, Barbara Hinterbuchinger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2018
Epigenetic alterations of the POMC promoter in tobacco dependenceMarc Muschler, Mathias Rhein, Andreas Ritter, et al.
Psychoneuroendocrinology|October 10, 2018
Smoking-induced changes in leptin serum levels and c/EBPalpha-related methylation status of the leptin core promotor during smoking cessationAlexander Glahn, Mathias Rhein, Helge Frieling, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 26, 2018
Desacylghrelin but not acylghrelin is reduced during smoking cessationMahsa Ardeshiripur, Mathias Rhein, Helge Frieling, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Emerging Drugs|April 12, 2024
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorderSophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Der Nervenarzt|January 11, 2020
[Addictive disorders in physicians]Ahmad Bransi, Lotta Winter, Alexander Glahn, et al.
Clinical Epigenetics|January 22, 2022
Leptin promoter methylation in female patients with painful multisomatoform disorder and chronic widespread painJohannes Achenbach, Mathias Rhein, Alexander Glahn, et al.
Deutsches Arzteblatt International|May 30, 2018
Alcohol Biomarkers in Clinical and Forensic ContextsHilke Andresen-Streichert, Alexander Müller, Alexander Glahn, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|November 24, 2020
[Central pontine myelinolysis during qualified alcohol withdrawal therapy. A case report]Phileas J Proskynitopoulos, Gregor Szycik, Stefan Bleich, et al.
BMC Psychiatry|June 26, 2015
Obsessive-compulsive disorder is a heterogeneous disorder: evidence from diffusion tensor imaging and magnetization transfer imagingAlexander Glahn, Tino Prell, Julian Grosskreutz, et al.
European Addiction Research|March 22, 2019
Thiamine Substitution in Alcohol Use Disorder: A Narrative Review of Medical GuidelinesNathalie Pruckner, Josef Baumgartner, Barbara Hinterbuchinger, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 7, 2018
Epigenetic alterations of the POMC promoter in tobacco dependenceMarc Muschler, Mathias Rhein, Andreas Ritter, et al.
Psychoneuroendocrinology|October 10, 2018
Smoking-induced changes in leptin serum levels and c/EBPalpha-related methylation status of the leptin core promotor during smoking cessationAlexander Glahn, Mathias Rhein, Helge Frieling, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 26, 2018
Desacylghrelin but not acylghrelin is reduced during smoking cessationMahsa Ardeshiripur, Mathias Rhein, Helge Frieling, et al.
Pageof 5